A100
De-identified Human Immune Atlas donor/sample detail for Neutrophil_LiverCancer_Nature_2022. The record preserves available public metadata while avoiding direct identifiers.
Primary Metadata
Core de-identified metadata fields migrated from the ImmuneAging donor manifest.
Donor ID
A100
Sample ID
A100_HCC
Dataset
Neutrophil_LiverCancer_Nature_2022
Cohort
Human liver cancer cohort, 124 patients
Age / Age Group
64 years
Sex
Male
Health Status
Hepatocellular carcinoma (HCC); TNM II; BCLC A
Tissue / Cell Source
tumor tissue
Modality
scRNA-seq
Cell Count
5,937
Analysis Status
Published scRNA-seq
UMAP Status
Ready
Metadata / Source Notes
Source: Nature Supplementary Table 1a/1b; patient samples: A100_HCC; library samples: A100_HCC; no. PB samples: 0; no. adjacent liver samples: 0; no. tumor samples: 1; differentiation: Moderate; venous invasion: 0; cirrhosis: 1
Additional Clinical / Source Fields
Supplementary source metadata retained from the migrated manifest where available.
cancer type
Hepatocellular carcinoma
cancer type short
HCC
tnm stage
II
bclc stage
A
virus
HBV
tumor size cm
4*3.5
differentiation
Moderate
venous invasion
0
cirrhosis
1
afp ug l
1.11
ca199 u ml
5.92
cea ug l
4.26
library count
1
library sample ids
A100_HCC
total reads
422145431
source reference
Xue et al., Nature 612, 141-147 (2022), Supplementary Table 1
data accession
PRJCA007744
article url